These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4179849)

  • 1. Poliomyelitis antibody titres in children and effect of live and inactivated poliovaccine.
    Reid D; Yetts R; Oddy CG; Benson PF
    Lancet; 1969 Mar; 1(7594):564-6. PubMed ID: 4179849
    [No Abstract]   [Full Text] [Related]  

  • 2. Poliovaccine at school entry.
    Lancet; 1969 Mar; 1(7594):561-2. PubMed ID: 4179845
    [No Abstract]   [Full Text] [Related]  

  • 3. RESPONSE TO ONE DOSE OF TRIVALENT ORAL POLIOVACCINE IN CHILDREN PREVIOUSLY IMMUNISED WITH SALK VACCINE: A COMPARISON OF LIQUID VACCINE AND A CAPSULE PRESENTATION.
    BEALE AJ; DAVIES JR; THROWER AL
    Lancet; 1965 Apr; 1(7391):879-81. PubMed ID: 14272682
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunization with inactivated poliovirus vaccine and attenuated type 3 poliovirus. I. Vaccination with the WM3 strain in 20 families.
    Böttiger M; Lagercrantz R
    J Pediatr; 1969 Jul; 75(1):30-8. PubMed ID: 4307138
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symposium on immunization. Immunization against poliomyelitis.
    Wehrle PF
    Arch Environ Health; 1967 Oct; 15(4):485-90. PubMed ID: 6054574
    [No Abstract]   [Full Text] [Related]  

  • 7. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sero-immunity to poliomyelitis virus in Sweden 10 years after introduction of vaccinations with inactivated poliovirus vaccine. A pilot study.
    Böttiger M
    Acta Pathol Microbiol Scand; 1969; 76(1):106-16. PubMed ID: 5350744
    [No Abstract]   [Full Text] [Related]  

  • 9. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries.
    Slater PE; Orenstein WA; Morag A; Avni A; Handsher R; Green MS; Costin C; Yarrow A; Rishpon S; Havkin O
    Lancet; 1990 May; 335(8699):1192-5; discussion 1196-8. PubMed ID: 1971043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poliovirus neutralizing antibody levels among preschool children.
    Poland JD; Plexico K; Flynt JW; Chin TD
    Public Health Rep (1896); 1968 Jun; 83(6):507-12. PubMed ID: 4968129
    [No Abstract]   [Full Text] [Related]  

  • 11. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polio immunity in Hamburg].
    Lennartz H
    Monatsschr Kinderheilkd (1902); 1970 Sep; 118(9):545-7. PubMed ID: 5521670
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine.
    Henry JL; Jaikaran ES; Davies JR; Tomlinson AJ; Mason PJ; Barnes JM; Beale AJ
    J Hyg (Lond); 1966 Mar; 64(1):105-20. PubMed ID: 5219018
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunization against poliomyelitis.
    Beale AJ
    Br Med Bull; 1969 May; 25(2):148-52. PubMed ID: 4319086
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
    Goldblum N; Kra-Oz Z; Swartz T
    Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains.
    Minor PD; Dunn G; Ramsay ME; Brown D
    J Med Virol; 2005 Jan; 75(1):153-60. PubMed ID: 15543587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection.
    Ogra PL; Karzon DT; Righthand F; MacGillivray M
    N Engl J Med; 1968 Oct; 279(17):893-900. PubMed ID: 20617594
    [No Abstract]   [Full Text] [Related]  

  • 19. Paralytic poliomyelitis in children with or without immunization against poliomyelitis.
    Nakao T; Chiba S; Horino K; Chiba Y
    Tohoku J Exp Med; 1971 Oct; 105(2):123-7. PubMed ID: 4334612
    [No Abstract]   [Full Text] [Related]  

  • 20. Booster effect of oral poliovaccine. Trials in persons previously immunized with inactivated vaccine.
    McCollough RH; Glezen WP; Lamb GA; Chin TD
    Am J Dis Child; 1969 Feb; 117(2):161-8. PubMed ID: 4303394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.